 Maria Cavasin
Concepts (273)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ventricular Remodeling | 14 | 2021 | 276 | 1.300 |
Why?
| | Histone Deacetylases | 7 | 2018 | 210 | 0.870 |
Why?
| | Myocardial Infarction | 10 | 2024 | 1209 | 0.850 |
Why?
| | Myocardium | 15 | 2024 | 939 | 0.760 |
Why?
| | Oligopeptides | 5 | 2010 | 269 | 0.730 |
Why?
| | Hypertrophy, Right Ventricular | 3 | 2021 | 150 | 0.700 |
Why?
| | Histone Deacetylase Inhibitors | 6 | 2021 | 220 | 0.620 |
Why?
| | Receptors, Endothelin | 2 | 2014 | 50 | 0.610 |
Why?
| | Endothelin Receptor Antagonists | 2 | 2010 | 62 | 0.500 |
Why?
| | Hypertension, Pulmonary | 5 | 2021 | 1980 | 0.490 |
Why?
| | Phosphodiesterase 5 Inhibitors | 1 | 2014 | 35 | 0.430 |
Why?
| | Angiotensin II | 7 | 2021 | 97 | 0.420 |
Why?
| | Rats | 17 | 2022 | 5597 | 0.390 |
Why?
| | Myocytes, Cardiac | 10 | 2025 | 556 | 0.390 |
Why?
| | Heart | 4 | 2007 | 636 | 0.380 |
Why?
| | Cardiomegaly | 5 | 2016 | 174 | 0.380 |
Why?
| | Rats, Sprague-Dawley | 11 | 2019 | 2527 | 0.370 |
Why?
| | Transcription Factors | 4 | 2024 | 1741 | 0.340 |
Why?
| | Cell Proliferation | 4 | 2021 | 2496 | 0.340 |
Why?
| | Blood Pressure | 10 | 2022 | 1769 | 0.330 |
Why?
| | Muscle, Smooth, Vascular | 2 | 2021 | 452 | 0.330 |
Why?
| | Heart Ventricles | 6 | 2021 | 760 | 0.320 |
Why?
| | Heart Failure | 7 | 2022 | 2323 | 0.320 |
Why?
| | Testosterone | 2 | 2005 | 419 | 0.320 |
Why?
| | Animals | 38 | 2025 | 38058 | 0.310 |
Why?
| | Kidney | 5 | 2022 | 1495 | 0.310 |
Why?
| | Hemodynamics | 4 | 2018 | 1121 | 0.290 |
Why?
| | Thymosin | 2 | 2006 | 5 | 0.290 |
Why?
| | Angiotensin-Converting Enzyme Inhibitors | 4 | 2004 | 221 | 0.280 |
Why?
| | Mice, Inbred C57BL | 12 | 2024 | 5992 | 0.270 |
Why?
| | Liver Cirrhosis | 1 | 2010 | 288 | 0.270 |
Why?
| | Azepines | 3 | 2024 | 107 | 0.270 |
Why?
| | Mice | 24 | 2025 | 18339 | 0.260 |
Why?
| | Nuclear Proteins | 2 | 2024 | 748 | 0.260 |
Why?
| | Serine Endopeptidases | 2 | 2007 | 128 | 0.260 |
Why?
| | Vascular Remodeling | 2 | 2021 | 205 | 0.260 |
Why?
| | Fibrosis | 7 | 2022 | 548 | 0.250 |
Why?
| | Glomerulosclerosis, Focal Segmental | 1 | 2007 | 43 | 0.250 |
Why?
| | Triazoles | 3 | 2024 | 184 | 0.250 |
Why?
| | Disease Models, Animal | 13 | 2024 | 4557 | 0.250 |
Why?
| | Nanotubes, Carbon | 1 | 2025 | 48 | 0.220 |
Why?
| | Kidney Cortex | 1 | 2004 | 27 | 0.210 |
Why?
| | Ventricular Dysfunction, Left | 2 | 2018 | 392 | 0.210 |
Why?
| | Myocardial Reperfusion Injury | 1 | 2024 | 137 | 0.200 |
Why?
| | Liver | 2 | 2010 | 1887 | 0.200 |
Why?
| | Histocompatibility Antigens Class II | 1 | 2024 | 364 | 0.190 |
Why?
| | Pulmonary Artery | 2 | 2021 | 1134 | 0.190 |
Why?
| | Macrophages | 6 | 2024 | 1511 | 0.190 |
Why?
| | Antihypertensive Agents | 3 | 2010 | 510 | 0.190 |
Why?
| | Cells, Cultured | 7 | 2024 | 4154 | 0.190 |
Why?
| | Collagen | 7 | 2007 | 456 | 0.180 |
Why?
| | Myofibrils | 1 | 2022 | 49 | 0.180 |
Why?
| | Sarcomeres | 1 | 2022 | 98 | 0.180 |
Why?
| | Ramipril | 2 | 2001 | 6 | 0.180 |
Why?
| | Myocytes, Smooth Muscle | 2 | 2021 | 266 | 0.180 |
Why?
| | Gonadal Steroid Hormones | 1 | 2003 | 144 | 0.170 |
Why?
| | Dual-Specificity Phosphatases | 1 | 2021 | 10 | 0.170 |
Why?
| | Tetrazoles | 2 | 2001 | 50 | 0.170 |
Why?
| | Heart Murmurs | 1 | 2021 | 14 | 0.170 |
Why?
| | Biocompatible Materials | 1 | 2025 | 435 | 0.170 |
Why?
| | Angiotensin I | 1 | 2000 | 7 | 0.170 |
Why?
| | Tissue Engineering | 1 | 2025 | 442 | 0.160 |
Why?
| | Cell Cycle Proteins | 1 | 2024 | 628 | 0.160 |
Why?
| | Hydrogels | 2 | 2025 | 700 | 0.160 |
Why?
| | Imidazoles | 2 | 2001 | 254 | 0.160 |
Why?
| | Vascular Endothelial Growth Factor A | 1 | 2022 | 557 | 0.150 |
Why?
| | Extracellular Matrix | 2 | 2021 | 553 | 0.150 |
Why?
| | Male | 25 | 2024 | 72315 | 0.150 |
Why?
| | Estradiol | 1 | 2003 | 533 | 0.150 |
Why?
| | Reperfusion Injury | 1 | 2022 | 300 | 0.140 |
Why?
| | Regional Blood Flow | 2 | 2012 | 514 | 0.140 |
Why?
| | Thermogenesis | 1 | 2018 | 45 | 0.140 |
Why?
| | Cardiomyopathies | 1 | 2022 | 338 | 0.140 |
Why?
| | Hypertension | 4 | 2011 | 1263 | 0.140 |
Why?
| | Fibroblasts | 3 | 2024 | 1034 | 0.140 |
Why?
| | Adipose Tissue, Brown | 1 | 2018 | 59 | 0.140 |
Why?
| | Myofibroblasts | 1 | 2019 | 143 | 0.140 |
Why?
| | Drug Discovery | 2 | 2016 | 155 | 0.130 |
Why?
| | Mice, Knockout | 7 | 2024 | 3121 | 0.130 |
Why?
| | High-Throughput Screening Assays | 2 | 2016 | 175 | 0.130 |
Why?
| | Tryptophan Hydroxylase | 1 | 2016 | 54 | 0.120 |
Why?
| | Intracellular Signaling Peptides and Proteins | 1 | 2019 | 459 | 0.120 |
Why?
| | Fatty Liver | 1 | 2018 | 251 | 0.120 |
Why?
| | Enzyme Inhibitors | 3 | 2016 | 824 | 0.120 |
Why?
| | Protease Inhibitors | 2 | 2007 | 102 | 0.110 |
Why?
| | Chromatin | 1 | 2019 | 561 | 0.110 |
Why?
| | Hypoxia | 2 | 2013 | 1199 | 0.110 |
Why?
| | Ventricular Function, Right | 1 | 2017 | 297 | 0.110 |
Why?
| | Captopril | 2 | 2004 | 11 | 0.110 |
Why?
| | Transcription Factor CHOP | 1 | 2014 | 32 | 0.110 |
Why?
| | Matrix Metalloproteinase 2 | 2 | 2004 | 56 | 0.100 |
Why?
| | Acute Kidney Injury | 1 | 2022 | 865 | 0.100 |
Why?
| | Ovariectomy | 2 | 2005 | 162 | 0.100 |
Why?
| | Matrix Metalloproteinase 9 | 2 | 2004 | 132 | 0.100 |
Why?
| | Pyridines | 2 | 2022 | 605 | 0.100 |
Why?
| | Muscular Atrophy | 1 | 2014 | 89 | 0.100 |
Why?
| | Stroke Volume | 4 | 2014 | 651 | 0.100 |
Why?
| | Adenylate Kinase | 1 | 2013 | 27 | 0.100 |
Why?
| | Histone Deacetylase 6 | 3 | 2022 | 17 | 0.090 |
Why?
| | Ventricular Function, Left | 3 | 2014 | 541 | 0.090 |
Why?
| | Calcinosis | 1 | 2014 | 234 | 0.090 |
Why?
| | Endoplasmic Reticulum | 1 | 2014 | 266 | 0.090 |
Why?
| | Vascular Diseases | 1 | 2014 | 251 | 0.090 |
Why?
| | Benzamides | 1 | 2012 | 224 | 0.080 |
Why?
| | Portal Pressure | 1 | 2010 | 4 | 0.080 |
Why?
| | Receptor, Endothelin B | 1 | 2010 | 48 | 0.080 |
Why?
| | Time Factors | 6 | 2014 | 7173 | 0.080 |
Why?
| | Connectin | 2 | 2022 | 42 | 0.080 |
Why?
| | Hepatic Stellate Cells | 1 | 2010 | 14 | 0.080 |
Why?
| | Receptor, Endothelin A | 1 | 2010 | 63 | 0.080 |
Why?
| | Gene Expression Regulation | 3 | 2018 | 2608 | 0.080 |
Why?
| | Hypertension, Portal | 1 | 2010 | 66 | 0.080 |
Why?
| | Carrier Proteins | 1 | 2013 | 737 | 0.070 |
Why?
| | Heart Defects, Congenital | 1 | 2017 | 914 | 0.070 |
Why?
| | RNA-Binding Proteins | 1 | 2013 | 462 | 0.070 |
Why?
| | Endothelin-1 | 1 | 2010 | 184 | 0.070 |
Why?
| | Nephrosclerosis | 1 | 2008 | 6 | 0.070 |
Why?
| | Piperidines | 1 | 2010 | 217 | 0.070 |
Why?
| | Peptides, Cyclic | 1 | 2010 | 275 | 0.070 |
Why?
| | Receptors, Chemokine | 1 | 2008 | 47 | 0.070 |
Why?
| | Pyrimidines | 1 | 2012 | 532 | 0.070 |
Why?
| | Sex Factors | 2 | 2022 | 2112 | 0.070 |
Why?
| | Heart Rate | 4 | 2007 | 855 | 0.070 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2014 | 653 | 0.070 |
Why?
| | Female | 11 | 2022 | 78271 | 0.070 |
Why?
| | Glomerular Mesangium | 1 | 2007 | 21 | 0.070 |
Why?
| | Histones | 1 | 2013 | 669 | 0.060 |
Why?
| | Random Allocation | 2 | 2008 | 363 | 0.060 |
Why?
| | Arginine Vasopressin | 1 | 2007 | 44 | 0.060 |
Why?
| | Substance P | 1 | 2007 | 39 | 0.060 |
Why?
| | Heart Function Tests | 2 | 2004 | 59 | 0.060 |
Why?
| | Heart Rupture | 2 | 2004 | 4 | 0.060 |
Why?
| | Chronic Disease | 2 | 2004 | 1813 | 0.060 |
Why?
| | Castration | 1 | 2005 | 15 | 0.060 |
Why?
| | Sulfonamides | 1 | 2010 | 580 | 0.060 |
Why?
| | Hydroxamic Acids | 2 | 2018 | 94 | 0.060 |
Why?
| | Gene Expression Regulation, Enzymologic | 2 | 2017 | 269 | 0.060 |
Why?
| | Case-Control Studies | 3 | 2021 | 3604 | 0.060 |
Why?
| | Indoles | 2 | 2014 | 501 | 0.060 |
Why?
| | Rupture | 1 | 2005 | 91 | 0.060 |
Why?
| | Reactive Oxygen Species | 1 | 2008 | 621 | 0.060 |
Why?
| | Gene Expression | 1 | 2010 | 1490 | 0.060 |
Why?
| | Hydroxyproline | 1 | 2004 | 18 | 0.050 |
Why?
| | Obesity | 1 | 2018 | 3077 | 0.050 |
Why?
| | Injections | 1 | 2025 | 196 | 0.050 |
Why?
| | Thiazolidines | 1 | 2004 | 13 | 0.050 |
Why?
| | Heart Rupture, Post-Infarction | 1 | 2004 | 2 | 0.050 |
Why?
| | Neutrophil Infiltration | 1 | 2004 | 104 | 0.050 |
Why?
| | Growth Inhibitors | 1 | 2004 | 39 | 0.050 |
Why?
| | Humans | 13 | 2025 | 144759 | 0.050 |
Why?
| | Signal Transduction | 4 | 2024 | 5226 | 0.050 |
Why?
| | Dipeptides | 1 | 2004 | 57 | 0.050 |
Why?
| | Epigenesis, Genetic | 2 | 2019 | 684 | 0.050 |
Why?
| | Muscle, Skeletal | 1 | 2014 | 1795 | 0.050 |
Why?
| | Particle Size | 1 | 2025 | 411 | 0.050 |
Why?
| | Materials Testing | 1 | 2025 | 354 | 0.050 |
Why?
| | Proline | 1 | 2004 | 83 | 0.050 |
Why?
| | Thiazoles | 1 | 2004 | 135 | 0.050 |
Why?
| | Organ Specificity | 1 | 2004 | 312 | 0.050 |
Why?
| | Nephrectomy | 1 | 2004 | 158 | 0.050 |
Why?
| | Models, Biological | 2 | 2013 | 1821 | 0.050 |
Why?
| | Nitriles | 1 | 2004 | 205 | 0.050 |
Why?
| | Orchiectomy | 1 | 2003 | 74 | 0.050 |
Why?
| | Glomerular Filtration Rate | 2 | 2022 | 760 | 0.050 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2022 | 138 | 0.050 |
Why?
| | Thiophenes | 1 | 2022 | 128 | 0.040 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2025 | 276 | 0.040 |
Why?
| | Temperature | 1 | 2025 | 679 | 0.040 |
Why?
| | Elastic Modulus | 1 | 2022 | 121 | 0.040 |
Why?
| | Transforming Growth Factor beta1 | 1 | 2022 | 178 | 0.040 |
Why?
| | Receptors, Bradykinin | 1 | 2001 | 5 | 0.040 |
Why?
| | Microscopy, Atomic Force | 1 | 2022 | 134 | 0.040 |
Why?
| | Acute Disease | 1 | 2004 | 1030 | 0.040 |
Why?
| | Cytoprotection | 1 | 2001 | 55 | 0.040 |
Why?
| | Models, Cardiovascular | 1 | 2002 | 195 | 0.040 |
Why?
| | NF-kappa B | 1 | 2024 | 661 | 0.040 |
Why?
| | Protein Isoforms | 2 | 2013 | 402 | 0.040 |
Why?
| | Transforming Growth Factor beta | 2 | 2019 | 479 | 0.040 |
Why?
| | Survival Rate | 1 | 2005 | 2089 | 0.040 |
Why?
| | Angiotensin Receptor Antagonists | 1 | 2001 | 114 | 0.040 |
Why?
| | Vasoconstrictor Agents | 1 | 2021 | 144 | 0.040 |
Why?
| | Interleukin-10 | 1 | 2022 | 309 | 0.040 |
Why?
| | Protein Binding | 2 | 2019 | 2273 | 0.040 |
Why?
| | Body Weight | 1 | 2004 | 976 | 0.040 |
Why?
| | Cardiac Output | 1 | 2000 | 179 | 0.040 |
Why?
| | Organ Size | 1 | 2000 | 463 | 0.040 |
Why?
| | Polymerase Chain Reaction | 2 | 2013 | 1054 | 0.040 |
Why?
| | Systole | 2 | 2014 | 178 | 0.040 |
Why?
| | Nitric Oxide | 1 | 2004 | 897 | 0.040 |
Why?
| | MAP Kinase Signaling System | 1 | 2021 | 310 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 361 | 0.040 |
Why?
| | Survival Analysis | 1 | 2002 | 1382 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2004 | 790 | 0.040 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2019 | 266 | 0.030 |
Why?
| | Adipose Tissue, White | 1 | 2018 | 43 | 0.030 |
Why?
| | Cell Adhesion Molecules | 1 | 2019 | 178 | 0.030 |
Why?
| | Enhancer Elements, Genetic | 1 | 2019 | 192 | 0.030 |
Why?
| | Myosins | 1 | 2018 | 136 | 0.030 |
Why?
| | Echocardiography | 1 | 2000 | 652 | 0.030 |
Why?
| | Drug Therapy, Combination | 2 | 2014 | 1047 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2018 | 261 | 0.030 |
Why?
| | Inflammation | 2 | 2008 | 2878 | 0.030 |
Why?
| | Isoenzymes | 1 | 2017 | 299 | 0.030 |
Why?
| | Phenotype | 1 | 2024 | 3162 | 0.030 |
Why?
| | Molecular Imaging | 1 | 2016 | 55 | 0.030 |
Why?
| | RNA Polymerase II | 1 | 2019 | 351 | 0.030 |
Why?
| | Small Molecule Libraries | 1 | 2016 | 111 | 0.030 |
Why?
| | Ketocholesterols | 1 | 2014 | 8 | 0.030 |
Why?
| | Animals, Newborn | 1 | 2017 | 902 | 0.030 |
Why?
| | Serotonin | 1 | 2016 | 293 | 0.030 |
Why?
| | Ezetimibe | 1 | 2014 | 24 | 0.030 |
Why?
| | Azetidines | 1 | 2014 | 45 | 0.030 |
Why?
| | Simvastatin | 1 | 2014 | 60 | 0.030 |
Why?
| | HEK293 Cells | 1 | 2016 | 744 | 0.030 |
Why?
| | Apolipoproteins E | 1 | 2014 | 94 | 0.030 |
Why?
| | Immunoblotting | 1 | 2013 | 300 | 0.020 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 40 | 0.020 |
Why?
| | Adaptation, Physiological | 1 | 2017 | 570 | 0.020 |
Why?
| | Chromatin Immunoprecipitation | 1 | 2013 | 139 | 0.020 |
Why?
| | Transcriptome | 1 | 2019 | 1045 | 0.020 |
Why?
| | Energy Metabolism | 1 | 2018 | 935 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 341 | 0.020 |
Why?
| | Cell Cycle | 1 | 2013 | 596 | 0.020 |
Why?
| | Cardiovascular Diseases | 2 | 2014 | 2168 | 0.020 |
Why?
| | Adenoviridae | 1 | 2011 | 199 | 0.020 |
Why?
| | Atherosclerosis | 1 | 2014 | 409 | 0.020 |
Why?
| | Insulin Resistance | 1 | 2018 | 1241 | 0.020 |
Why?
| | Flow Cytometry | 1 | 2013 | 1173 | 0.020 |
Why?
| | RNA Interference | 1 | 2011 | 476 | 0.020 |
Why?
| | Lipids | 1 | 2014 | 710 | 0.020 |
Why?
| | RNA, Small Interfering | 1 | 2011 | 635 | 0.020 |
Why?
| | Reproducibility of Results | 1 | 2016 | 3409 | 0.020 |
Why?
| | Probability | 1 | 2008 | 310 | 0.020 |
Why?
| | Albuminuria | 1 | 2008 | 190 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2002 | 11679 | 0.020 |
Why?
| | Reference Values | 1 | 2008 | 797 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2013 | 2050 | 0.010 |
Why?
| | Aged, 80 and over | 1 | 2018 | 8265 | 0.010 |
Why?
| | Blotting, Western | 1 | 2008 | 1187 | 0.010 |
Why?
| | Neovascularization, Pathologic | 1 | 2007 | 286 | 0.010 |
Why?
| | NG-Nitroarginine Methyl Ester | 1 | 2004 | 49 | 0.010 |
Why?
| | Connective Tissue Growth Factor | 1 | 2004 | 27 | 0.010 |
Why?
| | Middle Aged | 2 | 2018 | 35875 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2008 | 1716 | 0.010 |
Why?
| | Immediate-Early Proteins | 1 | 2004 | 48 | 0.010 |
Why?
| | Renal Circulation | 1 | 2004 | 75 | 0.010 |
Why?
| | Cell Movement | 1 | 2008 | 965 | 0.010 |
Why?
| | Nitric Oxide Synthase | 1 | 2004 | 235 | 0.010 |
Why?
| | Kidney Glomerulus | 1 | 2004 | 128 | 0.010 |
Why?
| | Lung | 1 | 2016 | 4109 | 0.010 |
Why?
| | Sensitivity and Specificity | 1 | 2008 | 1985 | 0.010 |
Why?
| | Hypertrophy, Left Ventricular | 1 | 2004 | 124 | 0.010 |
Why?
| | Rats, Inbred WKY | 1 | 2003 | 37 | 0.010 |
Why?
| | Rats, Inbred SHR | 1 | 2003 | 37 | 0.010 |
Why?
| | Infant | 1 | 2017 | 10034 | 0.010 |
Why?
| | Diastole | 1 | 2003 | 143 | 0.010 |
Why?
| | Mast Cells | 1 | 2004 | 146 | 0.010 |
Why?
| | Cell Division | 1 | 2004 | 766 | 0.010 |
Why?
| | Intercellular Signaling Peptides and Proteins | 1 | 2004 | 381 | 0.010 |
Why?
| | Mice, Transgenic | 1 | 2007 | 2182 | 0.010 |
Why?
| | Receptor, Bradykinin B2 | 1 | 2001 | 4 | 0.010 |
Why?
| | Receptor, Angiotensin, Type 2 | 1 | 2001 | 8 | 0.010 |
Why?
| | Receptor, Angiotensin, Type 1 | 1 | 2001 | 25 | 0.010 |
Why?
| | Monocytes | 1 | 2004 | 538 | 0.010 |
Why?
| | Mice, Inbred Strains | 1 | 2001 | 397 | 0.010 |
Why?
| | Aged | 1 | 2018 | 25913 | 0.010 |
Why?
| | Neutrophils | 1 | 2004 | 1134 | 0.010 |
Why?
| | Adolescent | 1 | 2017 | 22428 | 0.010 |
Why?
| | DNA | 1 | 2004 | 1463 | 0.010 |
Why?
| | Child | 1 | 2017 | 22633 | 0.010 |
Why?
| | Adult | 1 | 2018 | 40449 | 0.010 |
Why?
| | Disease Progression | 1 | 2001 | 2847 | 0.010 |
Why?
| | Biomarkers | 1 | 2004 | 4271 | 0.010 |
Why?
|
|
Cavasin's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|